Europe Active Pharmaceutical Ingredients Market Analysis and Forecasts to 2020

Report Overview

Table of Contents

951.12

Select License Type

£951.12	Electronic License Electronic License An electronic version (mostly PDF, but can be Excel or PPT), which is either available for immediate download or will be sent via email by the Publisher of the report. The licencing for an electronic version is for use by the purchaser ONLY.
£1,902.24	Site License Site License An electronic version (mostly PDF, but can be Excel or PPT). Where the report(s) is intended for use by more than one individual, across for example, a site, an office, or a division or country.
£2,853.36	Corporate License Corporate License An electronic version (mostly PDF, but can be Excel or PPT). Where the report(s) is/are intended for use by an organisation in its entirety. For example, if reports are put on an Intranet or if they are distributed or used by more than one office, division, or country operation, then a Corporate Licence is required.

£951.12	Add to Wishlist
Change Currency	GBP EURO USD
	Order By Fax

Market	Chemicals
Report Type	Market Research
Country	Europe
Published	12 July 2009
Number of Pages	127
Report Delivery	Email
Delivery Lead Time	-
Publisher	Global Markets Direct
File Format	-

Report: analysis of the Active Pharmaceutical Ingredients market in Europe

This report will provide an analysis of the Active Pharmaceutical Ingredients market in key countries of Europe. The report will provide in-depth analysis of volume and revenue of the Active Pharmaceutical Ingredients market in Europe. The pricing trend of the market will also be analyzed in the report. This report also contains detailed market share analysis of top companies operating in the region.

Scope

- Detailed analysis of volumes and revenues of Active Pharmaceutical Ingredients in all the major countries and forecasts till 2020
- Detailed analysis of the end applications of Active Pharmaceutical Ingredients in all the major countries
- Detailed analysis and forecasts of Active Pharmaceutical Ingredients prices in all the major countries
- Thorough analysis of key drivers of growth of the Active Pharmaceutical Ingredients market in all the major countries
- Detailed analysis of the market share of the major Active Pharmaceutical Ingredients producing companies in the major countries

Reasons to buy

- The report acts as a guide to the industry professionals and beginners to gain significant understanding about the Active Pharmaceutical Ingredients market in Europe
- To identify the most attractive geographies, markets and sectors to increase business
- Develop custom strategies based on the current and forecasted trends in the volumes and revenues of Active Pharmaceutical Ingredients market
- Benchmark different geographies by the historic and forecasted growth of volumes and revenues of Active Pharmaceutical Ingredients
- Benchmark your company with the top Active Pharmaceutical Ingredient producers with comprehensive information of the market share of top companies operating in the region

Speak to an Advisor

Call us on
+44 (0) 203 086 8600

Select License Type

£951.12	Electronic License Electronic License An electronic version (mostly PDF, but can be Excel or PPT), which is either available for immediate download or will be sent via email by the Publisher of the report. The licencing for an electronic version is for use by the purchaser ONLY.
£1,902.24	Site License Site License An electronic version (mostly PDF, but can be Excel or PPT). Where the report(s) is intended for use by more than one individual, across for example, a site, an office, or a division or country.
£2,853.36	Corporate License Corporate License An electronic version (mostly PDF, but can be Excel or PPT). Where the report(s) is/are intended for use by an organisation in its entirety. For example, if reports are put on an Intranet or if they are distributed or used by more than one office, division, or country operation, then a Corporate Licence is required.

£951.12	Add to Wishlist
Change Currency	GBP EURO USD

1 Table Of Contents 2
1.1 List of Tables 8
1.2 List of Figures 9
2 Introduction 11
2.1 What is this Report About? 11
2.2 GMD Report Coverage 11
2.3 Definitions 11
3 Executive Summary 12
3.1 Market Introduction and Overview 12
3.2 Industry Challenges 12
3.3 Market Drivers 13
3.4 Market Restraints 13
3.5 Total Market Revenue Forecasts to 2020 14
3.6 Revenue Share Analysis by Product Types 15
3.7 Competitive Landscape 16
3.8 Conclusion 16
4 Europe Active Pharmaceutical Ingredients Market 17
4.1 Market Definition and Overview 17
4.2 Product Types 18
4.2.1 Types Based on Synthesis Routes 18
4.2.2 Types based on Customer Base 19
4.3 Industry Structure 20
4.4 Product Life Cycle Analysis 22
4.4.1 Synthetic API 23
4.4.2 Biotech API 23
4.4.3 High Potency API (HPAPI) 23
4.4.4 Peptide APIs 23
4.5 Industry Challenges 24
4.5.1 Market Maturity is a Key Challenge for the Producers of API in Europe 24
4.5.2 High Cost Restricts Development of New Drugs 25
4.5.3 Highly Fragmented Nature of the Market Intensifies the Competition Among the Producers 25
4.5.4 Regulatory Challenges Affect the API Market 25
4.6 Market Drivers 26
4.6.1 Increasing Demand in the Generic Sector Spurs the Growth of European API Market 26
4.6.2 Overall Growth in the Pharmaceutical Industry Drives the Growth of the European API Market 27
4.6.3 Growth in Biopharmaceuticals Enable the Growth of the API Market in Europe 27
4.7 Market Restraints 27
4.7.1 Increasing Patent Expiries Lead to Reduced Growth of the European API Market 27
4.7.2 Decreasing Focus on Innovative Drugs Dampen the Growth of the European API Market 27
4.7.3 Price Erosion Restricts the Revenue Growth of the European API Market 28
4.8 Total Revenue Forecasts 28
4.9 Analysis by Product Types Based on Synthesis Routes 30
4.9.1 Revenue Share Analysis 30
4.9.2 Synthetic API Market Analysis 31
4.9.3 Biotech API Market Analysis 39
4.9.4 Revenue Share Trend Analysis of Product Types by Synthesis Routes 47
4.10 Analysis of Synthetic API Market by Customer Base 48
4.10.1 Revenue Share Analysis 48
4.10.2 Innovative Synthetic API Market Analysis 49
4.10.3 Generic Synthetic API Market Analysis 56
4.10.4 Revenue Share Analysis by Customer Base 63
4.11 Analysis by Therapeutic Applications 64
4.12 Analysis by Countries 65
4.13 Market Trends 67
4.13.1 Increasing Focus on HPAPI 67
4.13.2 Increasing Number of Development Projects in Therapeutic Peptide Area 67
4.14 Market Share Analysis 68
5 United Kingdom Active Pharmaceutical Ingredients Market 69
5.1 Market Overview 69
5.2 SWOT Analysis of the UK API Market 69
5.2.1 Strengths 69
5.2.2 Weaknesses 70
5.2.3 Opportunities 70
5.2.4 Threats 71
5.3 Market Drivers 71
5.3.1 Increasing Demand for Generic Drugs Fuels the Growth of the API Market in the United Kingdom 71
5.3.2 Growth in Ageing Population Aids in the Increasing Demand for APIs 71
5.3.3 Increase in the Prevalence of Heart Disease Boosts the growth of APIs for Cardiovascular Therapeutic Area 72
5.4 Market Restraints 73
5.4.1 Reduction in Health Care Spending Bound to Restrict the Growth of the API Market in the UK 73
5.4.2 Price Erosion Pulls Down the Growth of the API Market in the UK 73
5.5 Total Revenue Forecasts 74
5.6 Revenue Share Analysis by Product Types 76
5.7 Revenue Forecasts of Synthetic API by Customer Base 78
5.8 Revenue Share Analysis of Synthetic API Market by Customer Base 81
5.9 Analysis by Therapeutic Applications 84
6 Germany Active Pharmaceutical Ingredients Market 86
6.1 Market Overview 86
6.2 SWOT Analysis of Germany API Market 86
6.2.1 Strengths 87
6.2.2 Weaknesses 87
6.2.3 Opportunities 87
6.2.4 Threats 87
6.3 Market Drivers 87
6.3.1 Increasing Focus on the Generic Drugs Set to Boost the Growth of the API Market in Germany 87
6.3.2 The Drug Development Projects Support the Growth of the API Market in Germany 88
6.3.3 Growth in the Ageing Population 89
6.4 Market Restraints 89
6.4.1 Slowdown in the Growth of the Innovative Sector Restricts the Growth of the API Market 89
6.4.2 Decreasing Number of Pharmaceuticals in Germany Pulls Down the Growth of German API Market 89
6.5 Total Revenue Forecasts 91
6.6 Revenue Share Analysis by Product Types 93
6.7 Revenue Forecasts of Synthetic API by Customer Base 95
6.8 Revenue Share Analysis of Synthetic API Market by Customer Base 96
6.9 Analysis by Therapeutic Applications 99
7 France Active Pharmaceutical Ingredients Market 101
7.1 Market Overview 101
7.2 SWOT Analysis of the France API Market 101
7.2.1 Strengths 102
7.2.2 Weaknesses 102
7.2.3 Opportunities 102
7.2.4 Threats 102
7.3 Market Drivers 102
7.3.1 Attempts to Develop Generic Drug Market as a Cost-containment Measure Spurs the Growth of API Market in France 102
7.3.2 Development in Biotechnology in France Favors Growth in Biotech API 103
7.4 Market Restraints 103
7.4.1 Slowdown in the Innovative Drugs Sector Due to the Financial Crisis Restrains the Growth of the API Market in France 103
7.4.2 Patent Expiries Dampen the Growth of the France API Market 103
7.5 Total Revenue Forecasts 103
7.6 Revenue Share Analysis by Product Types 106
7.7 Revenue Forecasts of Synthetic API Market by Customer Base 107
7.8 Revenue Share Analysis of Synthetic API Market by Customer Base 109
7.9 Revenue Share Analysis by Therapeutic Applications 111
8 Italy Active Pharmaceutical Ingredients Market 113
8.1 Market Overview 113
8.2 SWOT Analysis of Italian API Market 113
8.2.1 Strengths 114
8.2.2 Weaknesses 114
8.2.3 Opportunities 114
8.2.4 Threats 114
8.3 Market Drivers 114
8.3.1 Growth in Generic Drugs Sector Drives the Growth of Italian API Market 114
8.3.2 Ageing Population Boosts the Growth of the API Market in Italy 114
8.4 Market Restraints 115
8.4.1 Cost-containment Measures by the Italian Government Bound to Restrict the Growth of the API Market 115
8.4.2 Price Cuts Prove to be Detrimental to the Growth of the API Market in Italy 115
8.5 Total Revenue Forecasts 115
8.6 Revenue Share Analysis by Product Types 118
8.7 Revenue Forecasts of Synthetic API Market by Customer Base 119
8.8 Revenue Share Analysis of Synthetic API Market by Customer Base 121
8.9 Analysis by Therapeutic Applications 123
9 Appendix 125
9.1 Methodology 125
9.1.1 Coverage 125
9.1.2 Secondary Research 126
9.1.3 Primary Research 126
9.1.4 Expert Panel Validation 127
9.2 Unit of Measure 127
9.3 Contact Us 127
9.4 About Global Markets Direct 127
9.5 Disclaimer 127

1.1 List of Tables
Table 1: Europe API Market, Total Revenue Forecasts, 2000-2020 28
Table 2: Europe API Market, Revenue Share by Product Types, 2008 30
Table 3: Europe Synthetic API Market, Revenue Forecasts, 2000-2020 33
Table 4: Europe Synthetic API Market, Revenue Share Analysis by Countries, 2008 35
Table 5: Europe Biotech API Market, Revenue Forecasts, 2000-2020 41
Table 6: Europe Biotech API Market, Revenue Share Analysis by Countries, 2008 43
Table 7: Europe Synthetic API Market, Revenue Share Analysis by Sectors Based on Customer Base, 2008 48
Table 8: Europe Innovative Synthetic API Market, Revenue Forecasts, 2000-2020 51
Table 9: Europe Innovative Synthetic API Market, Revenue Forecasts, 2000-2020 53
Table 10: Europe Generic Synthetic API Market, Revenue Forecasts, 2000-2020 57
Table 11: Europe Generic Synthetic API Market, Revenue Share Analysis by Countries, 2008 59
Table 12: Europe API Market, Revenues Shares by Countries, 2008 65
Table 13: UK API Market, Total Revenue Forecasts by Product Types, 2000-2020 74
Table 14: UK API Market, Revenue Share Trend Analysis by Product Types, 2000-2020 77
Table 15: UK Synthetic API Market, Revenue Forecasts by Customer Base, 2000-2020 78
Table 16: UK Synthetic API Market, Revenue Share Trend Analysis by Customer Base, 2000-2020 81
Table 17: UK API Market, Revenue Share by Therapeutic Class, 2008 84
Table 18: Germany API Market, Revenue Forecasts by Product Types, 2000-2020 91
Table 19: Germany API Market, Revenue Share Trend Analysis by Product Types, 2000-2020 93
Table 20: Germany Synthetic API Market, Revenue Forecasts by Customer Base, 2000-2020 95
Table 21: Germany Synthetic API Market, Revenue Share Trend Analysis by Customer Base, 2000-2020 97
Table 22: Germany API Market, Revenue Share by Therapeutic Class, 2008 99
Table 23: France API Market, Total Revenue Forecasts by Product Types, 2000-2020 104
Table 24: France API Market, Revenue Share Trend Analysis by Product Types, 2000-2020 106
Table 25: France API Market, Revenue Forecasts by Customer Base, 2000-2020 107
Table 26: France API Market, Revenue Forecasts by Customer Base, 2000-2020 109
Table 27: France API Market, Revenue Share by Therapeutic Class, 2008 111
Table 28: Italy API Market, Revenue Forecasts by Product Types, 2000-2020 116
Table 29: Italy API Market, Revenue Share Trend Analysis by Product Types, 2000-2020 118
Table 30: Italy Synthetic API Market, Revenue Forecasts by Customer Base, 2000-2020 120
Table 31: Italy Synthetic API Market, Revenue Share Trend Analysis by Customer Base, 2000-2020 122
Table 32: Italy API Market, Revenue Share by Therapeutic Class, 2008 123

1.2 List of Figures
Figure 1: Europe Active Pharmaceutical Ingredients Market, Revenue Forecasts, 2000-2020 14
Figure 2: Europe API Market, Revenue Share by Product Types, 2008 15
Figure 3: Europe API Market, Product Types 18
Figure 4: Europe API Market, Value Chain, 2008 20
Figure 5: Europe Active Pharmaceutical Ingredients Market, Product Life Cycle Analysis, 2008 22
Figure 6: Europe Active Pharmaceutical Ingredients Market, Pharmaceutical Expenditure of Countries as Percentage of Total Healthcare Expenditure, 2005 24
Figure 7: Europe API Market, Market Drivers and Restraints, 2008-2020 26
Figure 8: Europe API Market, Total Revenue Forecasts, 2000-2020 29
Figure 9: Europe API Market, Revenue Share by Product Types, 2008 31
Figure 10: Europe Synthetic API Market, Revenue Forecasts, 2000-2020 34
Figure 11: Europe Synthetic API Market, Revenue Share Analysis by Countries, 2008 36
Figure 12: Europe Synthetic API Market, Comparison of Countries by Revenue Growth Rates, 2008-2020 37
Figure 13: Europe Synthetic API Market, Revenue Share Trend Analysis by Countries, 2000-2020 38
Figure 14: Europe Biotech API Market, Revenue Forecasts, 2000-2020 42
Figure 15: Europe Biotech API Market, Revenue Share Analysis by Countries, 2008 44
Figure 16: Europe Biotech API Market, Comparison of Revenue Growth Rates by Countries, 2008-2020 45
Figure 17: Europe Biotech API Market, Revenue Share Trend Analysis, 2000-2020 46
Figure 18: Europe API Market, Revenue Share Trend Analysis by Product Types, 2000-2020 47
Figure 19: Europe Synthetic API Market, Revenue Share Analysis by Sectors Based on Customer Base, 2008 49
Figure 20: Europe Innovative Synthetic API Market, Revenue Forecasts, 2000-2020 52
Figure 21: Europe Innovative Synthetic API Market, Revenue Forecasts, 2000-2020 53
Figure 22: Europe Innovative Synthetic API Market, Comparison of Revenue Growth Rates by Countries, 2008-2020 54
Figure 23: Europe Innovative Synthetic API Market, Revenue Share Trend Analysis by Countries, 2000-2020 55
Figure 24: Europe Generic Synthetic API Market, Revenue Forecasts, 2000-2020 58
Figure 25: Europe Generic Synthetic API Market, Revenue Share Analysis by Countries, 2008 60
Figure 26: Europe Generic Synthetic API Market, Comparison of Revenue Growth Rates by Countries, 2008-2020 61
Figure 27: Europe Generic Synthetic API Market, Revenue Share Trend Analysis by Countries, 2000-2020 62
Figure 28: Europe Synthetic API Market, Revenue Share Trend Analysis by Customer Base, 2000-2020 63
Figure 29: Europe Active Pharmaceutical Ingredients Market, Comparison of Growth in Therapeutic Applications, 2008 64
Figure 30: Europe API Market, Revenues Shares by Countries, 2008 65
Figure 31: Europe API Market, Comparison of Revenue Growth Rates by Countries, 2008-2020 66
Figure 32: Europe Active Pharmaceutical Ingredients Market, Market Share Analysis of Companies by Revenues, 2008 68
Figure 33: UK API Market, SWOT Analysis, 2008 70
Figure 34: Active Pharmaceutical Ingredients Market, Growth in Ageing Population by Different Age Groups, 1948-2051 72
Figure 35: UK API Market, Total Revenue Forecasts by Product Types, 2000-2020 76
Figure 36: UK API Market, Revenue Share Trend Analysis by Product Types, 2000-2020 77
Figure 37: UK Synthetic API Market, Revenue Forecasts by Customer Base, 2000-2020 80
Figure 38: UK Synthetic API Market, Revenue Share Trend Analysis by Customer Base, 2000-2020 82
Figure 39: UK Synthetic API Market, Growth Rate Comparison by Customer Base, 2000-2020 83
Figure 40: UK API Market, Revenue Share by Therapeutic Class, 2008 85
Figure 41: Germany API Market, SWOT Profile, 2008 86
Figure 42: Germany API Market, Drug Development Projects by Therapeutic Areas, 2011 88
Figure 43: Germany Active Pharmaceutical Ingredients Market, Number of Pharmaceuticals, 2000-2008 90
Figure 44: Germany API Market, Revenue Forecasts by Product Types, 2000-2020 92
Figure 45: Germany API Market, Revenue Share Trend Analysis by Product Types, 2000-2020 94
Figure 46: Germany Synthetic API Market, Revenue Forecasts by Customer Base, 2000-2020 96
Figure 47: Germany Synthetic API Market, Revenue Share Trend Analysis by Customer Base, 2000-2020 97
Figure 48: Germany Synthetic API Market, Growth Rate Comparison by Customer Base, 2000-2020 98
Figure 49: Germany API Market, Revenue Share by Therapeutic Class, 2008 100
Figure 50: France API Market, SWOT Profile, 2008 101
Figure 51: France API Market, Total Revenue Forecasts by Product Types, 2000-2020 105
Figure 52: France API Market, Revenue Share Trend Analysis by Product Types, 2000-2020 106
Figure 53: France API Market, Revenue Forecasts by Customer Base, 2000-2020 108
Figure 54: France API Market, Revenue Forecasts by Customer Base, 2000-2020 109
Figure 55: France API Market, Comparison of Revenue Growth Rates by Customer Base, 2000-2020 110
Figure 56: France API Market, Revenue Share by Therapeutic Class, 2008 112
Figure 57: Italy API Market, SWOT Profile, 2008 113
Figure 58: Italy API Market, Revenue Forecasts by Product Types, 2000-2020 117
Figure 59: Italy API Market, Revenue Share Trend Analysis by Product Types, 2000-2020 119
Figure 60: Italy Synthetic API Market, Revenue Forecasts by Customer Base, 2000-2020 121
Figure 61: Italy Synthetic API Market, Revenue Share Trend Analysis by Customer Base, 2000-2020 122
Figure 62: Italy API Market, Revenue Share by Therapeutic Class, 2008 124
Figure 63: Global Markets Direct Methodology 125

Visitor Comments

All Comments

Change Currency

GBP

EURO

USD

Last Viewed

Europe Active Pharmaceutical Ingredients Market Analysis and Forecasts to 2020

EU 27 Retail Energy Price Dataset (October 2009)

Ethnic Hair, Beauty and Cosmetics Products in the U.S., 7th Edition

Ethiopia - Telecoms, Mobile, Broadband & Forecasts

Equatorial Guinea LNG Export and Import Markets to 2015 - Analysis and Forecasts of Terminal wise Capacity and Associated Contracts, LNG Trade movements and Prices

Chemicals Company Profiles

Find Chemicals Company Profiles, with SWOT analysis and latest financials.

Become an Affiliate

Do you manage an industry specific website or blog? Are you looking to monetise your web traffic further? Are you a B2B website?

Why not offer your visitors industry specific strategic market reports and company profiles? Our Affiliate Program enables you to provide quality content on your website and to earn money from passing on visitors to our website. If a sale is made from your visitor, you earn commission (a fixed percentage of the price of a product).

Custom Research

Cannot find what you need? We can tailor a report for you. Complete the Custom Research Form and we will provide a quote.

Chemicals	Type	Keywords Phrase All Words Any Word
Microsoft Windows users can hold the CTRL Key to select more than one sector or country at a time. Apple users can hold the CMD Key to do the same.	Country	Industry Sector
Publisher	Order By Relevance Date	Published In

Europe Active Pharmaceutical Ingredients Market Analysis and Forecasts to 2020

Select License Type

Report: analysis of the Active Pharmaceutical Ingredients market in Europe

Speak to an Advisor

Select License Type

Table of Contents

Visitor Comments

Change Currency

Last Viewed

Chemicals Company Profiles

Become an Affiliate

Custom Research

News

Market Insights

Companies And Markets

Customer Support

Corporate Accounts

Contact Details

Contrast settings

Text size settings

All
Afghanistan
Africa
Albania
Algeria
American Samoa
Andorra
Angola
Anguilla
Antigua and Barbuda
Argentina
Armenia
Aruba
Asia
Australia
Austria
Azerbaijan
Bahamas
Bahrain
Bangladesh
Barbados
Belarus
Belgium
Belize
Benin
Bermuda
Bhutan
Bolivia
Bosnia-Herzegovina
Botswana
Bouvet Island
Brazil
British Virgin Islands
Brunei
Bulgaria
Burkina Faso
Burundi
Cambodia
Cameroon
Canada
Cape Verde
Caribbean
Cayman Islands
Central African Republic
Central America
Central Europe
Chad
Chile
China
Christmas Island
Cocos (Keeling) Islands
Colombia
Comoros
Conch Republic
Cook Islands
Costa Rica
Croatia
Cuba
Cyprus
Czech Republic
Democratic Republic of Congo
Denmark
Djibouti
Dominica
Dominican Republic
Eastern Europe
Ecuador
Egypt
El Salvador
Equatorial Guinea
Eritrea
Estonia
Ethiopia
Europe
Falkland Islands
Faroe Islands
Fiji
Finland
France
French Guiana
French Southern Territories
Gabon
Gambia
Georgia
Germany
Ghana
Gibraltar
Global
Greece
Greenland
Grenada
Guadeloupe (French)
Guam (USA)
Guatemala
Guernsey
Guinea
Guinea Bissau
Guyana
Haiti
Heard Island and McDonald Islans
Holy See
Honduras
Hong Kong
Hungary
Iceland
India
Indonesia
Iran
Iraq
Ireland
Israel
Italy
Ivory Coast
Ivory Coast (Cote D`Ivoire)
Jamaica
Japan
Jersey
Jordan
Kazakhstan
Kenya
Kiribati
Kurdistan
Kuwait
Kyrgyzstan
Laos
Latvia
Lebanon
Lesotho
Liberia
Libya
Liechtenstein
Lithuania
Luxembourg
Macau
Macedonia
Madagascar
Malawi
Malaysia
Maldives
Mali
Malta
Marshall Islands
Martinique (French)
Mauritania
Mauritius
Mayotte
Mexico
Micronesia
Middle East
Moldova
Monaco
Mongolia
Montenegro
Montserrat
Morocco
Mozambique
Myanmar
Namibia
Nauru
Nepal
Netherlands
Netherlands Antilles
New Caledonia (French)
New Zealand
Nicaragua
Niger
Nigeria
Niue
Norfolk Island
North America
North Korea
Northern Mariana Islands
Norway
Oman
Pakistan
Palau
Palestinian Territory
Panama
Papua New Guinea
Paraguay
Peru
Philippines
Pitcairn Island
Poland
Polynesia (French)
Portugal
Puerto Rico
Qatar
Reunion
Romania
Russia
Rwanda
Saint Barthelemy
Saint Helena
Saint Kitts and Nevis
Saint Lucia
Saint Martin
Saint Pierre and Miquelon
Saint Vincent and Grenadines
Samoa
San Marino
Sao Tome and Principe
Saudi Arabia
Scandinavia
Schengen countries
Senegal
Serbia and Montenegro
Seychelles
Sierra Leone
Singapore
Slovakia
Slovenia
Solomon Islands
Somalia
South Africa
South America
South Georgia and the South Sandwich Islands
South Korea
Spain
Sri Lanka
Sudan
Suriname
Svalbard and Jan Mayen Islands
Swaziland
Sweden
Switzerland
Syria
Taiwan
Tajikistan
Tanzania
Thailand
Timor-Leste (East Timor)
Togo
Tokelau
Tonga
Trinidad and Tobago
Tunisia
Turkey
Turkmenistan
Turks and Caicos Islands
Tuvalu
Uganda
Ukraine
United Arab Emirates
United Kingdom
United States
United States Minor Outlying Islands
Uruguay
Uzbekistan
Vanuatu
Venezuela
Vietnam
Virgin Islands
Wallis and Futuna Islands
Western Sahara
Yemen
Zambia
Zimbabwe

All
Aerospace
Agriculture, Farming & Raw Materials
Automotive and Parts
Business Services
Chemicals
Construction
Consumer Goods
Defence
Energy and Utilities
Environmental
Finance and Banking
Food and Drink
Healthcare and Medical
Industrial
Information Technology
Leisure
Logistics
Media
Paper and Packaging
Publishing and Printing
Real Estate
Retail
Security
Telecommunications
Textiles and Clothing
Transportation
Travel